Molecular Imaging: Page 317

MITA asks CMS to reconsider PET agents

By AuntMinnie.com staff writers

The Medical Imaging and Technology Alliance (MITA) has requested that the U.S. Centers for Medicare and Medicaid Services (CMS) reconsider its national noncoverage decision (NCD) for PET tracers and remove exclusionary language that denies coverage for new PET imaging agents.

February 13, 2012

PET tracer FDDNP predicts Alzheimer's; MRI and Mediterranean diet

By Brian Casey

February 13, 2012

FDG-PET/CT helps manage retinoblastoma cancer

By Wayne Forrest

Optic nerve uptake at baseline on an FDG-PET/CT scan and response after neoadjuvant chemotherapy are strong predictors of event-free and overall survival for young children with stage III retinoblastoma, according to a study in the February issue of the Journal of Nuclear Medicine.

February 13, 2012

FDDNP-PET helps predict Alzheimer's progression

By Wayne Forrest

Using PET to image the radiopharmaceutical FDDNP in the brain, California researchers are showing how the accumulation of abnormal protein deposits is associated with Alzheimer's disease progression, according to a study in the February Archives of Neurology.

February 13, 2012

IAC streamlines accreditation process

By AuntMinnie.com staff writers

The Intersocietal Accreditation Commission (IAC) has renamed its six accrediting divisions and implemented multiple improvements aimed at streamlining the accreditation process.

February 12, 2012

Ultralow-dose CT enables PET correction

By Jude Dineley, PhD

The use of ultralow-dose CT scans for attenuation correction and respiratory gating of PET scans is feasible, concluded a recent study published in Physics in Medicine and Biology. Doses an order of magnitude lower than existing low-dose CT protocols on PET/CT scanners were achieved.

February 12, 2012